PSM wrote the House Energy & Commerce Committee in support of the Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act, to help protect the American drug supply from unsafely compounded medication.
Read More
FDA announced the seizure of dozens of counterfeit Ozempic 1mg injection pens labeled with an authentic lot number, PAR1229, but displaying the expiration and lot numbers for the product in the wrong place.
Read More
The FDA and Novo Nordisk are warning the public about counterfeit Ozempic injections circulating in the legitimate U.S. drug supply chain. The FDA announced the seizure of multiple batches of counterfeit Ozempic 1 mg injections, labeled with lot number PAR1229, on December 5, 2025. Their contents and safety are unverified and pose serious health risks.
Read More
MMWR field notes about Americans hospitalized after self-injecting imported Botox raise serious concerns about patient safety.
Read More
Surveys document consumer behaviors when purchasing medication from online pharmacies, finding that the public may not be aware of the dangers of IOPs.
Read More
What are the most important lessons from CNBC’s documentary about alternative funding programs (AFPs)?
Read More
CNBC aired a documentary about alternative funding programs that included interviews with PSM’s Shabbir Imber Safdar, HSI and FDA officials, as well as a representative from Gilead Sciences and from the companies supplying these drug.
Read More
The FDA warned websites in five countries to stop selling Americans unapproved cosmetic injections.
Read More
PSM sent a letter explaining how H.R. 5316 undermines critical patient safety protections.
Read More
The Maryland distributors were convicted at trial in Florida. A federal judged sentenced a pill press seller from China.
Read More